Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Boston Life Sciences raises $10 million

BLSI sold 1.4 million shares at $7.113

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE